BridgeBio has demonstrably boosted its development of an innovative solution for ATTR-CM, employing Attruby. Initial patient data suggests potential outcomes for individuals affected from the debilitating disease. The https://bridgebio238417.livebloggs.com/48922404/bridgebio-advances-amyloidosis-treatment-through-the-drug